Abstract: The present disclosure describes compositions and methods for treating cancer. Embodiments relate to a cell modified to express one or more molecules at a level that is higher or lower than the level of the one or more molecules expressed by a cell that has not been modified to express the one or more molecules, wherein the one or more molecules comprise Cavin3, ZBED2, and MYC.
Type:
Grant
Filed:
September 30, 2021
Date of Patent:
April 2, 2024
Assignees:
Innovative Cellular Therapeutics Holdings, Ltd., Innovative Cellular Therapeutics, Inc.
Inventors:
Zhiyuan Cao, Lei Xiao, Yuzhe Peng, Wei Ding, Wensheng Wang